Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 5,140 | 7,310 | 5,398 | 6,060 | 7,332 |
| Cost of Goods | 990 | 1,510 | 1,500 | 1,540 | 1,310 |
| Gross Profit | 4,140 | 5,830 | 3,890 | 4,480 | 6,040 |
| Operating Expenses | 14,970 | 9,640 | 9,840 | 11,170 | 11,470 |
| Operating Income | -9,830 | -3,330 | -5,442 | -6,110 | -5,138 |
| Interest Expense | 0 | 3,010 | 1,350 | 0 | 0 |
| Other Income | -460 | 10,740 | 322 | 200 | 5,188 |
| Pre-tax Income | -10,290 | 4,400 | -6,470 | -5,910 | 50 |
| Income Tax | -1,460 | -4,701 | -40 | 1 | 40 |
| Net Income Continuous | -8,829 | 9,101 | -6,425 | -1,316 | -4,662 |
| Net Income | $-8,829 | $9,101 | $-6,425 | $-1,316 | $-4,662 |
| EPS Basic Total Ops | -0.35 | 0.36 | -0.26 | -0.05 | -0.19 |
| EPS Basic Continuous Ops | -0.35 | 0.36 | -0.26 | -0.05 | -0.19 |
| EPS Diluted Total Ops | -0.35 | 0.36 | -0.26 | -0.05 | -0.19 |
| EPS Diluted Continuous Ops | -0.35 | 0.36 | -0.26 | -0.05 | -0.19 |
| EBITDA(a) | $-9,010 | $-3,330 | $-5,442 | $-5,280 | $-4,438 |